Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 9470Neoplasms 6584Prostatic Neoplasms 4397Colorectal Neoplasms 3975Lung Neoplasms 3638Carcinoma, Non-Small-Cell Lung 3579Pancreatic Neoplasms 2476Carcinoma, Hepatocellular 2409Leukemia, Myeloid, Acute 2264Multiple Myeloma 2118Stomach Neoplasms 2107Neoplasm Metastasis 1911Head and Neck Neoplasms 1867Ovarian Neoplasms 1771Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1729Brain Neoplasms 1697Rectal Neoplasms 1675Melanoma 1654Colonic Neoplasms 1629Leukemia 1499Uterine Cervical Neoplasms 1497Recurrence 1483Esophageal Neoplasms 1310Glioblastoma 1305Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Peptides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Healthy Adults × Clear all
NCT03643068 2018-11-06

Phase 1A Study of the Safety of KSP/QRH Dimer

University of Michigan

Phase 1 Completed
26 enrolled

Healthy Adults

NCT03161418 2017-12-05

Study of the Safety of KSP Heptapeptide (KSP-910638G)

University of Michigan

Phase 1 Completed
26 enrolled

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon âš¡